Author

Wesley C. Minto

Observed names: Minto Wesley, W Minto, Wesley Minto

Institution: Gilead Sciences (United States)

Observed institutions: Gilead Sciences (United States), BioMarin (United States)

OpenAlex ID: A5014337196

IL‐31 levels correlate with pruritus in patients with cholestatic and metabolic liver diseases and is farnesoid X receptor responsive in NASH

2022 · Jun Xu, Ya Wang, et al. · Hepatology · 60

Induction of ER Stress by an AAV5 BDD FVIII Construct Is Dependent on the Strength of the Hepatic-Specific Promoter

2020 · Sylvia Fong, Britta Handyside, et al. · Molecular Therapy — Methods & Clinical Development · 44

Clearance of Heparan Sulfate and Attenuation of CNS Pathology by Intracerebroventricular BMN 250 in Sanfilippo Type B Mice

2017 · Mika Aoyagi-Scharber, Danielle Crippen-Harmon, et al. · Molecular Therapy — Methods & Clinical Development · 36

Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitis

2023 · Claudia D. Fuchs, Natalie Sroda, et al. · JHEP Reports · 21

Prophylactic Prednisolone Promotes AAV5 Hepatocyte Transduction Through the Novel Mechanism of AAV5 Coreceptor Platelet-Derived Growth Factor Receptor Alpha Upregulation and Innate Immune Suppression

2023 · Britta Handyside, Lening Zhang, et al. · Human Gene Therapy · 6

Histologic characterization of the progression of central nervous system pathology in the mucopolysaccharidosis IIIB (MPS IIIB, Sanfilippo syndrome type B) mouse model and bio-distribution and efficacy of the intracerebroventricular enzyme replacement therapy, BMN 250

2016 · Anil Bagri, Danielle Harmon, et al. · Molecular Genetics and Metabolism · 1

P0126 GS-8670: An Intestinally Targeted Farnesoid X Receptor Agonist Restoring Barrier Integrity and Demonstrating Robust Efficacy in Colitis Models

2026 · J Chavarria-Smith, M Spalinger, et al. · Journal of Crohn s and Colitis

Integration of Chromogenic RNAscope In Situ Hybridization for Target Validation in Drug Discovery

2025 · Rosanna Win, Wesley Minto, et al. · Toxicologic Pathology

Human Translational Data and Preclinical Models Support LPAR1 Antagonist as a Candidate Treatment for Diabetic Kidney Disease

2022 · Monika Sharma, Swati Kaushik, et al. · Journal of the American Society of Nephrology

Inhibition of tumour progression locus 2 (TPL2) halts the progression of liver fibrosis in a stringent long term choline deficient high-fat diet (CdHFD) rat model

2022 · Milessa Silva Afonso, Rowena Suriben, et al. · Journal of Hepatology

Immunohistochemical analysis of mannose 6-phosphate/insulin-like growth factor 2 receptor in murine wild-type and mucopolysaccharidosis IIIB mutant central nervous system vasculature and implications for trans-blood brain barrier (BBB) transport

2016 · Anil Bagri, Danielle Harmon, et al. · Molecular Genetics and Metabolism

Time- and dose-dependent normalization of pathological lysosomal storage and biochemistry in the mucopolysaccharidosis ΙΙΙΒ (MPS ΙΙΙΒ, Sanfilippo syndrome type Β) mouse model by intracerebroventricular enzyme replacement therapy with ΒΜΝ 250, a ΝAGLU-ΙGF2 fusion pro

2016 · Mika Aoyagi-Scharber, Jon Vincelette, et al. · Molecular Genetics and Metabolism

Bmn250 (maglu‐igf2)の脳室内投与はmps Iiibマウスのリソソーム病理を正常化する

2016 · Aoyagi‐Scharber Mika, Crippen‐Harmon Danielle, et al. · 日本先天代謝異常学会雑誌

Works count: 13

Citation count: 168

H-index: 5

I10-index: 4